Biovotion has developed an accurate, wearable sensing technology, that allows for medical-quality vital sign monitoring (VSM) in daily life. The platform combines medical-quality VSM with design, wearability, convenience, and prices of the consumer market. The system (multi-sensor platform plus sophisticated algorithms) is intergrated into cloud infrastructures to provide users with data on par with standard hospital systems and can be stepwise expanded with additional physiological parameters. Current parameters include heart rate, blood oxygenation, blood perfusion, temperature and movement/activity. The first VSM generation is also expected to include heart rate variability, respiratory rate, energy expenditure, and sleep and stress monitoring. The management team is internationally recognised for its expertise in wearable monitoring. The company holds a broad IP portfolio.

Biovotion has developed an accurate, wearable sensing technology, that allows for medical-quality vital sign monitoring (VSM) in daily life. The platform combines medical-quality VSM with design, wearability, convenience, and prices of the consumer market. The system (multi-sensor platform plus sophisticated algorithms) is intergrated into cloud infrastructures to provide users with data on par with standard hospital systems and can be stepwise expanded with additional physiological parameters. Current parameters include heart rate, blood oxygenation, blood perfusion, temperature and movement/activity. The first VSM generation is also expected to include heart rate variability, respiratory rate, energy expenditure, and sleep and stress monitoring. The management team is internationally recognised for its expertise in wearable monitoring. The company holds a broad IP portfolio.

#1 doctor recommended personal EKG. The most clinically validated six-lead personal EKG. It’s a smart device you can trust.

AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. The FDA-cleared Kardia Mobile is the most clinically validated mobile ECG solution on the market and is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. This simple-to-use mobile device and app-based service provides instant analysis for detecting atrial fibrillation (AF) and normal sinus rhythm in an ECG. Kardia Pro is the first AI-enabled platform for doctors to monitor patients for the early detection of atrial fibrillation, the most common cardiac arrhythmia that leads to a five times greater risk of stroke. AliveCor was recognized by Fast Company as one of 2017's most innovative companies in health (#3). AliveCor is a privately-held company headquartered in Mountain View, California.